Haloperidol pretreatment unmasks the kappa opioid effects of U-50, 488H on cortical EEG and EEG power spectra in rats

Neuropharmacology. 1989 Aug;28(8):881-4. doi: 10.1016/0028-3908(89)90182-2.

Abstract

Adult female Sprague-Dawley rats were implanted with chronic cortical EEG electrodes and intravenous cannulae. U-50, 488H injection (5.0 mg/kg) produced initial EEG desynchrony and EEG spectral power that was mainly distributed over the zero to 10 Hz range, including a relatively small spectral peak in the 4-6 Hz band. In contrast, following haloperidol pretreatment (0.1 mg/kg), U-50, 488H injection produced high-voltage EEG bursts and a predominant EEG spectral peak in the 4-6 Hz band. These effects of U-50, 488H after haloperidol pretreatment were identical to those previously demonstrated with the benzomorphan kappa agonist ethylketocyclazocine. Thus, haloperidol pretreatment unmasked the kappa opioid effects of U-50, 488H.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Analgesics / pharmacology*
  • Animals
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / physiology
  • Electroencephalography*
  • Haloperidol / pharmacology*
  • Male
  • Pyrrolidines / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Opioid / physiology*
  • Receptors, Opioid, kappa

Substances

  • Analgesics
  • Pyrrolidines
  • Receptors, Opioid
  • Receptors, Opioid, kappa
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Haloperidol